Dr Reddys Labs

Dr Reddys Laboratories Ltd Key Ratios

NSEBSE

₹1,348.8

(2.25%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Dr Reddys Laboratories Ltd

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2022	Mar-2021	Mar-2020	Mar-2018
Growth matrix (%)
Revenue growth	13.11	8.73	22.65	0.59
Op profit growth	-2.64	56.65	5.06	-4.89
EBIT growth	5.26	52.1	34.89	-11.61
Net profit growth	11.83	-3.67	113.98	-26.72
Profitability ratios (%)
OPM	17.48	20.31	14.1	16.46
EBIT margin	14.32	15.39	11	10
Net profit margin	10.12	10.24	11.56	6.62
RoCE	14.25	15.22	10.81	8.12
RoNW	2.96	2.93	3.59	1.9
RoA	2.52	2.53	2.84	1.34
Per share ratios (₹)
EPS	131.16	117.28	121.9	54.96
Dividend per share	30	25	25	20
Cash EPS	61.12	43.46	51.92	-7.85
Book value per share	1,154.41	1,060.82	938.71	757.73
Valuation ratios
P/E	6.56	7.7	5.11	7.57
P/CEPS	14.08	20.77	12	-52.99
P/B	0.74	0.85	0.66	0.54
EV/EBIDTA	17.07	18.27	17.4	15.7
Payout (%)
Dividend payout	0	0	0	35.04
Tax payout	-29.38	-32.86	7.66	-32.43
Liquidity ratios
Debtor days	98.6	95.73	94.6	100.33
Inventory days	81.56	77.1	66.84	73.63
Creditor days	-48.75	-46.38	-39.69	-45.1
Leverage ratios
Interest coverage	-32.22	-30.23	-19.61	-18.13
Net debt / equity	0.05	0.05	0.12	0.38
Net debt / op. profit	0.25	0.24	0.81	2.04
Cost breakup (₹)
Material costs	-34.54	-31.91	-31.7	-28.28
Employee costs	-18.03	-19.05	-19.29	-22.51
Other costs	-29.93	-28.71	-34.89	-32.73